ASPC 2020 Virtual Summit on CVD Prevention

 

Videos
35:56

ASPC 2020 Virtual Summit on CVD Prevention

Integrating Imaging & Advanced Blood Testing for CVD Prevention/Management: How Do We Know If the Patient Is in Prediabetes Phase? Why Do Lipoproteins Become Atherogenic? What Is the Role of Non-Lifestyle Genetic Markers?

FEATURING Arthur Agatston
  • 483 views
  • March 24, 2021
  • 3
08:09

ASPC 2020 Virtual Summit on CVD Prevention

Implementation of FIND FH Into Clinical Care at Penn Medicine: Can Machine-Learning Algorithm Improve & Reduce Time in FH Diagnosis/Management? Is it Possible to Implement it Within a Large Healthcare System?

FEATURING Samip Sheth
  • 7 views
  • March 23, 2021
05:37

ASPC 2020 Virtual Summit on CVD Prevention

Lessons Learned from the ISCHEMIA Trial: How to Diagnose/Manage CAD After ISCHEMIA?

FEATURING David Maron
  • 389 views
  • March 17, 2021
  • 2
11:29

ASPC 2020 Virtual Summit on CVD Prevention

Managing Patients With Stable CAD: When to Consider the Cath Lab? What to Do Before Invasive Strategy Decisions? When to Revascularize for Unacceptable Angina? - ISCHEMIA Trial Highlights

FEATURING David Maron
  • 1,257 views
  • March 17, 2021
  • 8
21:16

ASPC 2020 Virtual Summit on CVD Prevention

ASPC Expert Discussion on Biologics Usage for CV Risk Reduction, Efficacy of Polypharmacy, Statin Usage in Elderly, Ischemia Trial, BP Intensity Control, and Optimal Medical Therapy Approach

FEATURING Christie Ballantyne, Ann Marie Navar, David Maron, Keith Ferdinand, Paul Ridker
  • 37 views
  • March 17, 2021
07:35

ASPC 2020 Virtual Summit on CVD Prevention

Continuity of Care for Patients With/At High Risk for CVD During COVID-19 Pandemic: How Can We Improve SoC? What Are the ASPC Recommendations?

FEATURING Amit Khera
  • 87 views
  • March 17, 2021
  • 1
08:31

ASPC 2020 Virtual Summit on CVD Prevention

Management of HF With Preserved Ejection Fraction: How Can We Prevent It? What Are the Pharmacological Treatment Recommendations for Stage C HF With Preserved EF?

FEATURING Douglas Schocken
  • 131 views
  • March 17, 2021
  • 1
18:46

ASPC 2020 Virtual Summit on CVD Prevention

How Can We Prevent the Majority of CV Events? What Are the Milion Hearts Priorities?

FEATURING Laurence Sperling
  • 349 views
  • March 17, 2021
  • 2
19:17

ASPC 2020 Virtual Summit on CVD Prevention

NIH Scientific Approach to Inclusive Excellence: Why Diversity Matters? How to Create Inclusive Scientific Environments Where Diverse Talent Thrives?

FEATURING Hannah A. Valantine
  • 8 views
  • March 17, 2021
10:53

ASPC 2020 Virtual Summit on CVD Prevention

ASPC CVD Prevention Panel Discussion: How Can We Educate Our Patients to Prevent CVD? What Happens With Atherosclerotic Plaque/Calcium Density in Menopause? How to Diagnose CMD When We Don’t Have All Available Technologies?

FEATURING Leslee Shaw, Nanette Wenger, Viviany Taqueti, Renee Bullock-Palmer, Erin Michos, Martha Gulati, Pam Taub
  • 18 views
  • March 17, 2021
05:07

ASPC 2020 Virtual Summit on CVD Prevention

Expert Discussion on Transdermal Hormone Replacement Therapy & How to Manage Pregnant COVID-19 Patients With CVD Risks? - 2020 ASPC Virtual Summit on CVD Prevention

FEATURING Leslee Shaw, Nanette Wenger, Viviany Taqueti, Renee Bullock-Palmer, Erin Michos, Martha Gulati, Pam Taub
  • 16 views
  • March 17, 2021
12:41

ASPC 2020 Virtual Summit on CVD Prevention

Disparities in the Use of Preventive Medications and Risk Factor Control in CHD Patients: Study Overview

FEATURING Kimberley Vu
  • 9 views
  • March 16, 2021
27:57

ASPC 2020 Virtual Summit on CVD Prevention

100 Years from C-Reactive Protein to Anti-Inflammatory Therapy for Atherosclerosis: A Brief History of Epidemiologic Discovery

FEATURING Paul Ridker
  • 59 views
  • March 16, 2021
  • 1
28:45

ASPC 2020 Virtual Summit on CVD Prevention

Apolipoprotein B & CVD Risk: How Can We Improve CVD Prevention With a Long-Term apoB Model? What Are the Benefits/Value of apoB? Why There Is apoB Resistance in the US vs. Europe?

FEATURING Allan Sniderman
  • 336 views
  • March 16, 2021
  • 5
32:07

ASPC 2020 Virtual Summit on CVD Prevention

Adverse Pregnancy Outcomes & CVD Risk: What Are the Risks and How to Manage Them Before/During Pregnancy & Postpartum?

FEATURING Renee Bullock-Palmer
  • 5 views
  • March 16, 2021
07:13

ASPC 2020 Virtual Summit on CVD Prevention

FH Visual Aids in Patient Education Research Highlights: Can Distribution of Visual Educational Materials Significantly Increase Referral for Identification & Treatment of Probable FH Patients?

FEATURING David M. Harmon
  • 16 views
  • March 16, 2021
05:51

ASPC 2020 Virtual Summit on CVD Prevention

HF With Preserved Ejection Fraction: How to Distinguish HFrEF & HFpEF? What Are the New Diagnostic Methods?

FEATURING Douglas Schocken
  • 19 views
  • March 16, 2021
15:01

ASPC 2020 Virtual Summit on CVD Prevention

Diagnosis/Management of CMD: How to Use Novel Imaging Tools to Understand the Prognosis of Diffuse CAD & CMD in Symptomatic Patients? How to Manage SIHD/CMD in Specific Population?

FEATURING Viviany Taqueti
  • 16 views
  • March 16, 2021
27:34

ASPC 2020 Virtual Summit on CVD Prevention

Atherosclerosis & MicroRNAs: How MicroRNAs Impacts Risk for Atherogenesis?

FEATURING Peter Toth
  • 93 views
  • March 16, 2021
  • 1
37:24

ASPC 2020 Virtual Summit on CVD Prevention

Primary Prevention by CAC vs. CTA: Which One Is Better and Why? - SCCT Expert Debate

FEATURING James Min, Khurram Nasir
  • 36 views
  • March 16, 2021
47:06

ASPC 2020 Virtual Summit on CVD Prevention

Jackson Heart Study Overview: Racial Disparity Trends, Risk Assessment, Hypertension Incidence, Genetics & Social Determinants of Risk

FEATURING Herman Taylor
  • 13 views
  • March 16, 2021
19:28

ASPC 2020 Virtual Summit on CVD Prevention

ASPC Panel Discussion on CV Risk Prevention With Nutrition, Hypertension, Resilience, and Hispanic Patient Population

FEATURING Keith Ferdinand, David Maron, Laurence Sperling, Ileana Pina, Herman Taylor
  • 16 views
  • March 16, 2021
20:21

ASPC 2020 Virtual Summit on CVD Prevention

Discussion on CTA/CAC for Primary Prevention, Genetic Testing, LDL Mutations, and Implementation of FIND FH Into Clinical Care - 2020 ASPC Virtual Summit on CVD Prevention

FEATURING Ron Blankstein, Salim Virani, Arthur Agatston, James Min, Samip Sheth, Khurram Nasir, Amit Khera
  • 24 views
  • March 16, 2021
28:23

ASPC 2020 Virtual Summit on CVD Prevention

New Insights Into Assessing Risk for Hispanic Patients: Why it Is Important to Discuss Risk Factors in Hispanics?

FEATURING Ileana Pina
  • 11 views
  • March 12, 2021
16:33

ASPC 2020 Virtual Summit on CVD Prevention

Menopause and Its Impact on Women's CVD Health: How to Assess Risk Factors? Can Hormone Theraphy Reduce CVD Risk?

FEATURING Erin Michos
  • 484 views
  • March 12, 2021
  • 2
14:00

ASPC 2020 Virtual Summit on CVD Prevention

Genetic Testing in Preventive Cardiology: Are Those With FH Mutation, for Any Given Observed LDL, at Higher Risk for CAD? Who to Test for FH, and What Are the Ordering Considerations?

FEATURING Amit Khera
  • 356 views
  • March 12, 2021
  • 3
14:55

ASPC 2020 Virtual Summit on CVD Prevention

Statin Usage in Athletes: Is There Increased Muscle Injury With Statins Usage? Can They Reduce Exercise Training Response? What Are the Administration Recommendations?

FEATURING Paul D. Thompson
  • 21 views
  • March 12, 2021
27:36

ASPC 2020 Virtual Summit on CVD Prevention

Sex Differences in Atherosclerosis: Is There a Sex Specific Phenotype for Atherosclerotic Plaque? Can Antiplatelet Therapy & Statins Improve CVD Outcomes?

FEATURING Leslee Shaw
  • 29 views
  • March 12, 2021
16:05

ASPC 2020 Virtual Summit on CVD Prevention

Polypill for CVD Prevention: When Is Polypharmacy Appropriate? Can Rosuvastatin + Candesartan + HCTZ Reduce CV Events?

FEATURING Keith Ferdinand
  • 164 views
  • March 12, 2021
  • 1
28:02

ASPC 2020 Virtual Summit on CVD Prevention

CVD Prevention for Women: What Are the Unique/Predominant Risk Factors in Women? Can Gender-Specific Management Improve ASCVD Outcomes?

FEATURING Nanette Wenger
  • 17 views
  • March 12, 2021